H14 Acquires Minority Stake in Unicamillus

Deal News | Jan 24, 2025 | Finance Community IT - 3 Private Equity

H14 Acquires Minority Stake in Unicamillus

H14, a family office managed by Barbara, Eleonora, and Luigi Berlusconi, has acquired a minority stake in the Saint Camillus International University of Health and Medical Sciences (Unicamillus), located in Rome. Founded in 2018 by Gianni Profita, Unicamillus is a private medical university that has experienced significant growth and digital transformation since its inception. The entrance of H14 as a minority stakeholder aims to solidify the university's presence in Italy, facilitate international collaborations, and invest in cutting-edge infrastructure, technology, and human capital. New Deal Advisors, led by partner Antonio Ficetti Gasco, conducted the financial due diligence for H14's investment.

Sectors

  • Private Equity
  • Higher Education
  • Healthcare

Geography

  • Italy – Unicamillus is based in Rome, Italy, and H14's investment aims to strengthen its presence in the Italian educational landscape.

Industry

  • Private Equity – The acquisition of a minority stake in Unicamillus by H14 falls under the Private Equity sector, where investments in private companies are made to support growth and development.
  • Higher Education – Unicamillus, being a medical university, is part of the Higher Education industry, focusing on training and research in the healthcare sector.
  • Healthcare – Since Unicamillus is a medical and health sciences university, it is intrinsically linked to the Healthcare industry through education and training of healthcare professionals.

Financials

  • Not Disclosed – The financial terms of H14's acquisition of a minority stake in Unicamillus have not been disclosed.

Participants

NameRoleTypeDescription
H14InvestorCompanyA family office managed by Barbara, Eleonora, and Luigi Berlusconi, involved in acquiring a minority stake in Unicamillus.
Saint Camillus International University of Health and Medical Science (Unicamillus)Target CompanyCompanyA private medical university founded in 2018 in Rome, offering education in health and medical sciences.
New Deal AdvisorsFinancial Due Diligence AdvisorCompanyProvided financial due diligence services to H14 for the acquisition of a minority stake in Unicamillus.
Gianni ProfitaFounder and Controlling ShareholderPersonFounder and controlling shareholder of Unicamillus.